{"id":4159,"date":"2020-08-26T09:18:52","date_gmt":"2020-08-26T09:18:52","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/allergy-in-vitro-diagnostics\/"},"modified":"2021-01-08T11:28:01","modified_gmt":"2021-01-08T11:28:01","slug":"allergy-in-vitro-diagnostics","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/allergy-in-vitro-diagnostics\/","title":{"rendered":"Allergy in-vitro diagnostics"},"content":{"rendered":"
Patients often show a wide range of varying symptoms and sensitization patterns against several allergens. Therefore diagnosing an allergic disease is always based on anamnesis, in-vivo testing and in-vitro diagnostics. In-vitro diagnostics in particular, i.e. the determination of specific IgE against the suspected allergens, are essential whenever an allergic response or severe reaction is suspected but furthermore also as a foundation for possible immunotherapy and its preparation. The preparation for immunotherapy requires the results of a quantitative test system like single allergen systems. These tests are expensive and need expensive laboratory equipment. With the RIDA qLine Allergy test, R-Biopharm AG has developed a sophisticated allergy in-vitro test system that combines both quantitative determination and very economic and easy handling.<\/p>\n
\nSupplier:<\/strong> R-Biopharm AG
\nWebsite:<\/strong> <\/a><\/p>\n